# Intraoperative Folate Targeted Fluorescence in Renal Cell Carcinoma

> **NCT02645409** · NA · COMPLETED · sponsor: **Chandru Sundaram** · enrollment: 14 (actual)

## Conditions studied

- Renal Cell Carcinoma

## Interventions

- **DRUG:** OTL38
- **DEVICE:** Intraoperative fluorescence imaging system

## Key facts

- **NCT ID:** NCT02645409
- **Lead sponsor:** Chandru Sundaram
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12-29
- **Primary completion:** 2018-03-20
- **Final completion:** 2019-04-02
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2020-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02645409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02645409, "Intraoperative Folate Targeted Fluorescence in Renal Cell Carcinoma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02645409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*